IBM Completes HRL Laboratories Acquisition to Boost Quantum Push
IBM sits 17% above its 52-week low of $199.19 on light trading volume (0.3× avg).
Summary
IBM has completed its acquisition of HRL Laboratories, a research lab known for advanced semiconductor and quantum technologies. The deal aligns with IBM's $10B quantum computing investment announced in June and comes after a rough Q2 that saw shares plunge 25%. HRL brings deep expertise in silicon-based quantum devices and advanced packaging, potentially accelerating IBM's quantum roadmap. No financial terms were disclosed, but the strategic fit is clear. Watch for integration updates and any impact on IBM's quantum hardware milestones.
At the time of this announcement, IBM was trading at $233.28 on NYSE in the Technology sector, with a market capitalization of approximately $220.6B. The 52-week trading range was $199.19 to $332.46. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.